Last reviewed · How we verify
NCT06313073
Neoadjuvant Radiotherapy for Breast Cancer
NA trial testing Neoadjuvant radiotherapy in Neoadjuvant Radiotherapy in 60 participants. Status unknown.
15 February 2026
Quick facts
| Lead sponsor | Changhai Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 April 2024 |
| Primary completion | 15 February 2026 |
| Estimated completion | 15 February 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Neoadjuvant radiotherapy
- adjuvant radiotherapy
Conditions studied
- Neoadjuvant Radiotherapy — all drugs for Neoadjuvant Radiotherapy →
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Changhai Hospital
Who can join
Adults 18 to 70, female only, with Neoadjuvant Radiotherapy or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the effects of neoadjuvant radiotherapy and adjuvant radiotherapy in patients with breast cancer. The main questions it aims to answer are: * The clinical effect of neoadjuvant radiotherapy for breast cancer was determined according to the postoperative specimens. * Evaluate the acute and late toxicity of preoperative radiotherapy Participants will be randomly divided into two groups: the neoadjuvant radiotherapy group and the adjuvant radiotherapy group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Early Radiation Therapy Response Assessment Using Multi-Scale Photoacoustic Imaging.
Lefebvre TL, Oraiopoulou ME, Bunce EV, Else TR, et al · · 2026 · PMID 41801228 · DOI 10.1002/advs.202509268
Verify or expand the search:
- PubMed search for NCT06313073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neoadjuvant radiotherapy
Trials testing the same drug.
- NCT06769919 — A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for · Phase 2, PHASE3 · not yet recruiting
- NCT06472752 — Neoadjuvant Radiotherapy for High-risk UTUC · not yet recruiting
- NCT05992870 — Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction · NA · recruiting
- NCT05216900 — Breast Reconstruction and Neoadjuvant Radiotherapy · NA · recruiting
- NCT05412225 — A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction · Phase 1 · recruiting
Other recruiting trials for Neoadjuvant Radiotherapy
Currently open trials in the same condition.
- NCT05992870 — Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction · NA · recruiting
Other Changhai Hospital trials
Trials by the same sponsor.
- NCT07490002 — Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC · Phase 2 · not yet recruiting
- NCT07464392 — FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis · NA · recruiting
- NCT07507071 — Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions · not yet recruiting
- NCT07481591 — Capsule Endoscopy in GI Bleeding: A Retrospective Study · not yet recruiting
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06313073 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changhai Hospital
- Last refreshed: 15 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06313073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing